Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accuracy, acquire, advisor, advisory, al, allegedly, alter, amid, Antitrust, appraisal, appraised, assumption, attention, automatically, aware, back, beneficial, breached, cancelled, captioned, cease, Chancery, Chin, claim, competent, complaint, compounded, consent, consummate, consummated, consummation, contemplated, court, covenant, coverage, cured, defense, delay, delaying, Denise, difficult, discourage, District, diversion, divert, diverted, earlier, Eastern, economic, endpoint, entirety, Ervin, failed, false, forego, foregoing, governmental, harm, Herbert, hire, ii, iii, incentivize, indemnification, independent, Indiana, influenced, injunction, injunctive, innovative, insurance, Janet, Joseph, jurisdiction, Kingdom, Knight, launched, lieu, Liu, lose, Lyndon, mailing, Matthew, McCracken, merge, merger, Milan, misleading, mm, Montgomery, motivate, mutual, Nanxi, nonpublic, Northern, ordinary, pendency, perfect, petition, plaintiff, preliminary, printing, prohibiting, properly, Proposal, proposed, prove, provision, proxy, publicly, purport, purported, purportedly, pursuit, Raymond, reaching, recommend, recommendation, refuse, rejected, relief, representation, requisite, rescissory, Richard, Singh, Southern, spread, stockholder, straight, Superior, Task, timeframe, timetable, Townsend, twelve, unfavorably, Union, unvested, violated, waiting, waived, waiver, warranty, Whitfield, withdrawn, written, York
Removed:
CMC, consulting, erythropoietin, inherent, runway, trial, typical
Filing tables
Filing exhibits
KIN similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND THE CHIEF FINANCIAL OFFICER
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Kindred Biosciences, Inc. (the “Company”) hereby certifies that, to his or her knowledge:
(i) The quarterly report on Form 10-Q for the period ended June 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 5, 2021 | By: /s/ Richard Chin | By: /s/ Wendy Wee | ||||||
| Name: Richard Chin, MD | Name: Wendy Wee | |||||||
| Title: Chief Executive Officer | Title: Chief Financial Officer | |||||||